DOCSLIB.ORG

Interpretive Guide for Amino Acids

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Interpretive Guide for Amino Acids Intervention Options LOW HIGH Essential Amino Acids Arginine (Arg) Arg Mn Histidine (His) Folate, His Isoleucine (Ile) * B6, Check for insulin insensitivity Leucine (Leu) * B6, Check for insulin insensitivity Lysine (Lys) Carnitine Vitamin C, Niacin, B6, Iron, a-KG Methionine(Met) * B6, á-KG, Mg, SAM Phenylalanine (Phe) * Iron,VitaminC,Niacin,LowPhediet Threonine(Thr) * B6, Zn Tryptophan(Trp) Trpor5-HTP Niacin, B6 Valine (Val) * B6, Check for insulin insensitivity Essential Amino Acid Derivatives Neuroendocrine Metabolism y-Aminobutyric Acid (GABA) a-KG, B6 Glycine (Gly) Gly Folate, B6,B2,B5 Serine (Ser) B6, Mn, Folate * Taurine (Tau) Tau, B6 Vit. E, Vit. C, B-Carotene, CoQ10, Lipoate Tyrosine(Tyr) Iron,Tyr,VitaminC,Niacin Cu, Iron, Vitamin C, B6 Ammonia/Energy Metabolism a-Aminoadipic Acid B6, a-KG Asparagine (Asn) Mg Aspartic Acid (Asp) a-KG, B6 Mg, Zn Citrulline (Cit) Mg, Aspartic acid Glutamic Acid (Glu) B6, a-KG Niacin, B6 Glutamine (Gln) a-KG, B6 Ornithine (Orn) Arg Mg, a-KG, B6 Sulfur Metabolism Cystine (Cys) NAC B2 Cystathionine B6 Homocystine (HCys) B6, Folate, B12, Betaine Additional Metabolites a-Amino-N-Butyric Acid a-KG, B6 B6, a-KG Alanine (Ala) * B6 Anserine Zn n-Alanine Lactobacillus and Bifidobacteria, B6 n-Aminoisobutyric Acid B6 Carnosine Zn Ethanolamine Mg Hydroxylysine (HLys) Vitamin C, Iron, a-KG Hydroxyproline (HPro) Vitamin C, Iron, a-KG 1-Methylhistidine Vitamin E, B12, Folate 3-Methylhistidine BCAAs, Vit. E, Vit. C, n-Carotene, CoQ10, Lipoate Phosphoethanolamine (PE) SAM, B12, Folate, Betaine Phosphoserine Mg Proline (Pro) a-KG Vitamin C, Niacin Sarcosine B2 * Use balanced or custom mixtures of essential amino acids Nordic Laboratiroes∙ Nygade 6, 3.sal ∙ 1164 Copenhagen K ∙ DenmarkTel: +45 33 75 1000 ∙ e-mail: [email protected] In association with ©Metametrix, Inc. All rights reserved Interpretive Guide for Amino Acids 2 Essential Amino Acids rich protein or inefficient metabolism. convert to succinate for use in the Krebs If other sulfur-containing AAs are low, (citric acid) cycle for energy generation. A r g i n i n e then enhance methionine utilization by Cofactors here are a-KG and vitamin B6. Low - often reflects a diet poor in high adding the necessary cofactors, quality protein, causing arginine to be magnesium and vitamin B6. G l y c i n e poorly absorbed. Because arginine is Low - possible generalized tissue loss, required for nitric oxide production, Phenylalanine glycine being part of the nitrogen pool deficiencies have wide-ranging effects Low - can result in altered thyroid and important in gluconeogenesis. on cardiovascular and other systems. function and catecholamine deficits Supplement glycine. High - may indicate a functional block including symptoms of depression, High - supplement vitamin B5, folic in the urea cycle. Manganese activates cognitive disorders, memory loss, acid, and vitamins B6, and B2 for the an arginase enzyme, so supplementing fatigue, and autonomic dysfunction. efficient metabolism of glycine to with manganese may help. Reduce lifestyle stressors and pyruvic acid for oxidation and for supplement phenylalanine. glutathione synthesis or H i s t i d i n e High - high protein intake or a block in gluconeogenesis. Low - check dietary protein, or malab- the conversion of phenylalanine to sorption if other essential AAs are low. tyrosine. Iron, vitamin C, and niacin are S e r i n e Low histidine is associated with necessary for this enzymatic step. Check Low - can lead to disordered rheumatoid arthritis, folate deficiency, tyrosine level and, if low, supplement methionine metabolism and deficits in and/or salicylate/steroid use. tyrosine and iron. acetylcholine synthesis. If simultaneous High - may indicate excessive protein high threonine or phosphoserine, then intake. If high 3-Methylhistidine, T h r e o n i n e need for vitamin B6, folate, and muscle protein breakdown is indicated. Low - can result in hypoglycemic manganese is indicated. symptoms, particularly if glycine High - when accompanied by low I s o l e u c i n e or serine is also low. Supplement threonine, indicates glucogenic Low - a chronic deficiency of this AA threonine/BCAAs. compensation and catabolism. can cause hypoglycemia and related High - excessive dietary intake or Supplement threonine and BCAAs. problems and loss of muscle mass or possible insufficient metabolism of inability to build muscle. threonine. The initial step here requires T a u r i n e High - large intake of this AA or (vitamin B6) and zinc is needed to Low - may increase risk for oxidative incomplete metabolism of it. If other phosphorylate vitamin B6 to its active stress, fat maldigestion, high cholesterol, BCAAs are high, add vitamin B6 to aid coenzyme form, so supplementation atherosclerosis, angina, arrythmias, and metabolism. with vitamin B6 and zinc can be helpful. seizure disorders. Supplement taurine or cysteine and vitamin B6, even if fresh L e u c i n e T r y p t o p h a n fish or lean meat is eaten. Females do not Low - potential catabolism of skeletal Low - commonly correlated with synthesize taurine as easily as males. muscle. Check 3-Methylhistidine to depression, insomnia, and schizophrenia. High - may be due to excessive confirm this. Supplementation with 5- inflammation in the body or to High - large intake of this AA or Hydroxytryptophan (5-HTP) may help. 5- supplementation of other amino acids. incomplete metabolism of it. If other HTP is one enzymatic step away from BCAAs are high, add vitamin B6 to aid serotonin. T y r o s i n e metabolism. High - possibly inadequate metabolism of Low - implicated in depression, tryptophan. Required nutrients for this hypothyroidism, and blood pressure L y s i n e process include niacin and vitamin B6. disorders. If phenylalanine is normal or Low - either poor dietary intake or too high (barring PKU), iron, vitamin C, and high intake of arginine. Low levels can V a l i n e niacin supplementation might be inhibit transamination of AA collagen Low - deficiency in this or other BCAAs indicated to help convert phenylalanine synthesis. If concurrent weakness or indicates potential muscle loss. If several to tyrosine. high triglycerides, add carnitine. High - essential AAs are low, check for adequate High - inadequate utilization of impaired metabolism of lysine. Add stomach acid. Supplement the BCAAs. tyrosine. Supplement the cofactors vitamin C, niacin, vitamin B6, a- High - excessive intake or vitamin B6 needed here including iron, copper, ketoglutarate and iron to enhance functional deficit. If other BCAAs are vitamin B6, and ascorbate. utilization of lysine. high, vitamin B6 should be given. Ammonia/Energy Metabolism M e t h i o n i n e Essential Amino Acid Low - possible poor-quality protein diet. Derivatives Neuroendocrine a -Aminoadipic acid Adverse effects on sulfur metabolism. Metabolism High - possible inhibition of lysine Improve dietary methionine intake or metabolism and lowered amine group supplement. (GABA) Gamma-aminobutyric acid transfer in the tissues. Supplement High - excessive intake of methionine- High - may reflect decreased ability to vitamin B6 and a-KG to facilitate the Interpretive Guide for Amino Acids 3 transamination conversion of á- High - a possible metabolic block in for energy can lead to muscle wasting. aminoadipic to á-ketoadipic acid. urea cycle, causing excess ammonia Supplement the branched-chain amino burden. Confirm by checking for high acids. A s p a r a g i n e glutamine, low glutamic acid. Low - can reflect functional need for A n s e r i n e magnesium in the conversion from Sulfur Metabolism High - high dietary intake of poultry can aspartic acid. contribute to elevate anserine. Zinc is High - Can indicate problems with C y s t i n e required for the normal conversion to ß- purine (therefore protein) synthesis. Low - possible dietary deficiency of alanine plus 1-methylhistidine methionine and/or cystine. Low cystine Aspartic Acid can impair taurine synthesis. ß - A l a n i n e Low - inhibits ammonia detoxification in High - excessive dietary intake or High - possible bowel toxicity due to ß- the urea cycle. Can be converted to impaired cystine metabolism. Converted to alanine production by intestinal bacteria oxaloactetate using B6 and á-KG and thus cysteine (reduced cystine) via a B2 and and/or Candida albicans. Possible cause enter the Krebs cycle. Low levels can copper-dependent step. Cystine is a major for food sensitivity reactions when reflect decreased cellular energy component of tissue antioxidant combined with low taurine and high 3- generation, seen as fatigue. Citric and mechanisms. methylhistidine, carnosine and/or aspartic acids can drive the Krebs (citric anserine, due to impaired renal tubular acid) cycle, when combined with B6 and á- Cystathionine resorption. Supplement B6 (to facilitate KG. High - possible B6 functional deficit as B6 amine group transfer). Bowel detox or High - sometimes seen in epilepsy and or P-5-P is required for the conversion of high potency Lactobacillus acidophilus stroke. Magnesium and zinc may cystathionine to cysteine. Hence low and Bifidobacteria can help with gut counteract high aspartic add levels. cysteine can result. dysbiosis. C i t r u l l i n e Homocystine ß-Aminoisobutyric acid High - can indicate a functional enzyme High - increased risk for atherosclerosis High - indicates lack of a transaminase block in the urea cycle, leading to an and abnormalities in the ocular, enzyme needed to metabolize this ammonia buildup. Supplement neurological and musculo-skeletal substance in the presence of á-KG, an magnesium and aspartic add to drive the systems. The enzyme that converts apparently benign phenomenon, seen in cycle. Lower protein intake is suggested homocysteine (reduced homocystine) to kwashiorkor (chronic protein in ammonia toxicities. cystathionine is B6 dependent; deficiency). remethylation of homocysteine to Glutamic Acid methionine requires B12, folate and C a r n o s i n e Low - can suggest mild hyper- betaine.
Recommended publications
  • Hydroxylation of the Eukaryotic Ribosomal Decoding Center Affects Translational Accuracy

    Hydroxylation of the Eukaryotic Ribosomal Decoding Center Affects Translational Accuracy

    Hydroxylation of the eukaryotic ribosomal decoding center affects translational accuracy Christoph Loenarza,1, Rok Sekirnika,2, Armin Thalhammera,2, Wei Gea, Ekaterina Spivakovskya, Mukram M. Mackeena,b,3, Michael A. McDonougha, Matthew E. Cockmanc, Benedikt M. Kesslerb, Peter J. Ratcliffec, Alexander Wolfa,4, and Christopher J. Schofielda,1 aChemistry Research Laboratory and Oxford Centre for Integrative Systems Biology, University of Oxford, Oxford OX1 3TA, United Kingdom; bTarget Discovery Institute, University of Oxford, Oxford OX3 7FZ, United Kingdom; and cCentre for Cellular and Molecular Physiology, University of Oxford, Oxford OX3 7BN, United Kingdom Edited by William G. Kaelin, Jr., Harvard Medical School, Boston, MA, and approved January 24, 2014 (received for review July 31, 2013) The mechanisms by which gene expression is regulated by oxygen Enzyme-catalyzed hydroxylation of intracellularly localized are of considerable interest from basic science and therapeutic proteins was once thought to be rare, but accumulating recent perspectives. Using mass spectrometric analyses of Saccharomyces evidence suggests it is widespread (11). Motivated by these cerevisiae ribosomes, we found that the amino acid residue in findings, we investigated whether the translation of mRNA to closest proximity to the decoding center, Pro-64 of the 40S subunit protein is affected by oxygen-dependent modifications. A rapidly ribosomal protein Rps23p (RPS23 Pro-62 in humans) undergoes growing eukaryotic cell devotes most of its resources to the tran- posttranslational hydroxylation. We identify RPS23 hydroxylases scription, splicing, and transport of ribosomal proteins and rRNA as a highly conserved eukaryotic subfamily of Fe(II) and 2-oxoglu- (12). We therefore reasoned that ribosomal modification is a tarate dependent oxygenases; their catalytic domain is closely re- candidate mechanism for the regulation of protein expression.
  • N-Acyl Taurines Are Endogenous Lipid Messengers That Improve Glucose Homeostasis

    N-Acyl Taurines Are Endogenous Lipid Messengers That Improve Glucose Homeostasis

    N-acyl taurines are endogenous lipid messengers that improve glucose homeostasis Trisha J. Grevengoeda, Samuel A. J. Trammella, Michele K. McKinneyb,c, Natalia Petersena, Rebecca L. Cardoned, Jens S. Svenningsena, Daisuke Ogasawarab,c, Christina C. Nexøe-Larsene, Filip K. Knopa,e,f,g, Thue W. Schwartza, Richard G. Kibbeyd, Benjamin F. Cravattb,c,1, and Matthew P. Gilluma,1 aNovo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark; bDepartment of Cell Biology, The Scripps Research Institute, La Jolla, CA 92037; cDepartment of Chemistry, The Scripps Research Institute, La Jolla, CA 92037; dDepartment of Internal Medicine, Yale School of Medicine, New Haven, CT 06519; eCenter for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, 2900 Hellerup, Denmark; fDepartment of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark; and gClinical Metabolic Physiology, Steno Diabetes Center Copenhagen, Gentofte, 2820 Hellerup, Denmark Contributed by Benjamin F. Cravatt, October 17, 2019 (sent for review September 19, 2019; reviewed by George Kunos and Richard Lehner) Fatty acid amide hydrolase (FAAH) degrades 2 major classes of involvement in the endocannabinoid system may have, to date, bioactive fatty acid amides, the N-acylethanolamines (NAEs) and overshadowed the study of NATs, the physiological functions N-acyl taurines (NATs), in central and peripheral tissues. A functional of which remain poorly understood despite their bioactivity and polymorphism in the human FAAH gene is linked to obesity and dysregulation in disease states (20–22). mice lacking FAAH show altered metabolic states, but whether these NATs have been identified by liquid chromatography-tandem phenotypesarecausedbyelevationsinNAEsorNATsisunknown.
  • Cloning and Expression of a Cdna Encoding the Transporter of Taurine

    Cloning and Expression of a Cdna Encoding the Transporter of Taurine

    Proc. Natl. Acad. Sci. USA Vol. 89, pp. 12145-12149, December 1992 Biochemistry Cloning and expression of a cDNA encoding the transporter of taurine and /8-alanine in mouse brain (neurotransmitters/membrane protein/moecular cloning) QING-RONG Liu, BEATRIZ L6PEZ-CORCUERA, HANNAH NELSON, SREEKALA MANDIYAN, AND NATHAN NELSON* Roche Institute of Molecular Biology, Roche Research Center, Nutley, NJ 07110 Communicated by Leon A. Heppel, September 8, 1992 (receivedfor review July 30, 1992) ABSTRACT A taurine/fl-alanine transporter was cloned hippocampus induced an increase in chloride permeability of from a mouse brain cDNA library by screening with a partial the cellular membranes (16, 17). Responses to all of those cDNA probe of the glycine transporter at low stringency. The substances were blocked by external strychnine, indicating deduced amino acid sequence predicts 590 amino acids with that they interacted with the same system. However, no typical characteristics of the sodium-dependent neurotrans- specific receptors for taurine or f-alanine could be identified. mitter transporters such as sequence homology and membrane Moreover, /3-alanine and taurine uptake systems could be topography. However, the calculated isoelectric point of the shared by other neurotransmitters. It was reported that a taurine/fi-alanine transporter is more acidic (pI = 5.98) than low-affinity GABA transporter accumulates taurine and those (pI > 8.0) ofother cloned neurotransmitter transporters. f3-alanine (18). The taurine transporter takes up /3-alanine Xenopus oocytes Injected with cRNA of the cloned transporter with high efficiency in neuronal and astroglial cells in culture. expressed uptake activities with K. = 4.5 FM for taurine and In this communication we report on the cloning and expres- K.
  • Significance of Urinary Hydroxyproline in Man

    Significance of Urinary Hydroxyproline in Man

    SIGNIFICANCE OF URINARY HYDROXYPROLINE IN MAN Darwin J. Prockop, Albert Sjoerdsma J Clin Invest. 1961;40(5):843-849. https://doi.org/10.1172/JCI104318. Find the latest version: https://jci.me/104318/pdf SIGNIFICANCE OF URINARY HYDROXYPROLINE IN MAN By DARWIN J. PROCKOP AND ALBERT SJOERDSMA (From the Section of Experimental Therapeutics, National Heart Institute, Bethesda, Md.) (Submitted for publication September 27, 1960; accepted January 12, 1961) Since nearly all of the hydroxyproline of the of Marfan's syndrome (2) reflect a rapid rate of body is found in collagen, it has been suggested collagen degradation. (1, 2) that the urinary excretion of this imino An incidental discovery in the study was that acid may be an important index of collagen me- the increase in urinary hydroxyproline after in- tabolism. The origin of urinary hydroxyproline, gestion of gelatin represents an increased excre- however, is not definitely established. The iso- tion of hydroxyproline peptides. This appears to topic studies of Stetten (3) in rats indirectly sug- be the first demonstration that significant amounts gested that most of the free and peptide hydroxy- of peptides can be excreted following ingestion of proline in the body arises from the breakdown of a protein. collagen, since she found that hydroxyproline-N'5 was not significantly incorporated into collagen. MATERIALS AND METHODS Ziff, Kibrick, Dresner and Gribetz (1), on the The 8 subjects utilized in the study were hospitalized other hand, observed an increased excretion of for periods of 3 to 12 weeks; 3 were patients with Mar- hydroxyproline when it was added to the diet of fan's syndrome, 2 of whom were previously shown to have elevated excretions of hydroxyproline (2).
  • Mendelian Randomization Study on Amino Acid Metabolism Suggests Tyrosine As Causal Trait for Type 2 Diabetes

    Mendelian Randomization Study on Amino Acid Metabolism Suggests Tyrosine As Causal Trait for Type 2 Diabetes

    nutrients Article Mendelian Randomization Study on Amino Acid Metabolism Suggests Tyrosine as Causal Trait for Type 2 Diabetes Susanne Jäger 1,2,* , Rafael Cuadrat 1,2, Clemens Wittenbecher 1,2,3, Anna Floegel 4, Per Hoffmann 5,6, Cornelia Prehn 7 , Jerzy Adamski 2,7,8,9 , Tobias Pischon 10,11,12 and Matthias B. Schulze 1,2,13 1 Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, 14558 Nuthetal, Germany; [email protected] (R.C.); [email protected] (C.W.); [email protected] (M.B.S.) 2 German Center for Diabetes Research (DZD), 85764 Neuherberg, Germany; [email protected] 3 Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA 4 Leibniz Institute for Prevention Research and Epidemiology-BIPS, 28359 Bremen, Germany; fl[email protected] 5 Human Genomics Research Group, Department of Biomedicine, University of Basel, 4031 Basel, Switzerland; per.hoff[email protected] 6 Institute of Human Genetics, Division of Genomics, Life & Brain Research Centre, University Hospital of Bonn, 53105 Bonn, Germany 7 Research Unit Molecular Endocrinology and Metabolism, Helmholtz Zentrum München, German Research Center for Environmental Health, 85764 Neuherberg, Germany; [email protected] 8 Chair of Experimental Genetics, Center of Life and Food Sciences Weihenstephan, Technische Universität München, 85354 Freising-Weihenstephan, Germany 9 Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, 8 Medical Drive,
  • H-Tyrosine-Glycine-Phenylalanine-Glycine-Glycine-OH for the Treatment of Chronic Idiopathic Myelofibrosis

    H-Tyrosine-Glycine-Phenylalanine-Glycine-Glycine-OH for the Treatment of Chronic Idiopathic Myelofibrosis

    European Medicines Agency Pre-authorisation Evaluation of Medicines for Human Use Document Date: London, 5 October 2009 Doc.Ref.: EMEA/COMP/1579/2003 Rev.1 Please note that this product was withdrawn from the Community Register of designated Orphan Medicinal Products in March 2009 on request of the Sponsor. Committee for Orphan Medicinal Products Public summary of positive opinion for orphan designation of H-Tyrosine-Glycine-Phenylalanine-Glycine-Glycine-OH for the treatment of chronic idiopathic myelofibrosis On 20 October 2003, orphan designation (EU/3/03/167) was granted by the European Commission to Abiogen Pharma S.p.A, Italy, for H-Tyrosine-Glycine-Phenylalanine-Glycine-Glycine-OH for the treatment of chronic idiopathic myelofibrosis. What is chronic idiopathic myelofibrosis? Chronic idiopathic myelofibrosis is a disease in which cancer cells are found in the blood and in the bone marrow. The bone marrow is the spongy tissue inside the large bones in the body. Normally the bone marrow makes cells called “blasts” that mature into several different types of blood cells that have specific functions in the body. These include red cells, white cells and platelets. Red blood cells carry oxygen and other materials to all tissues of the body. White blood cells fight infection. Platelets make the blood clot. When myelofibrosis develops, the bone marrow produces large number of abnormal blood cells. In chronic idiopathic myelofibrosis the abnormal population of cells produce substances that alter the growth media of bone marrow and makes bone marrow very dense and rigid. As the abnormal bone marrow environment is no more adequate for the cells, some migrate to other sites where proliferation and maturation take place.
  • (12) Patent Application Publication (10) Pub. No.: US 2007/0254315 A1 Cox Et Al

    (12) Patent Application Publication (10) Pub. No.: US 2007/0254315 A1 Cox Et Al

    US 20070254315A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2007/0254315 A1 Cox et al. (43) Pub. Date: Nov. 1, 2007 (54) SCREENING FOR NEUROTOXIC AMINO (60) Provisional application No. 60/494.686, filed on Aug. ACID ASSOCATED WITH NEUROLOGICAL 12, 2003. DSORDERS Publication Classification (75) Inventors: Paul A. Cox, Provo, UT (US); Sandra A. Banack, Fullerton, CA (US); Susan (51) Int. Cl. J. Murch, Cambridge (CA) GOIN 33/566 (2006.01) GOIN 33/567 (2006.01) Correspondence Address: (52) U.S. Cl. ............................................................ 435/721 PILLSBURY WINTHROP SHAW PITTMAN LLP (57) ABSTRACT ATTENTION: DOCKETING DEPARTMENT Methods for screening for neurological disorders are dis P.O BOX 105OO closed. Specifically, methods are disclosed for screening for McLean, VA 22102 (US) neurological disorders in a Subject by analyzing a tissue sample obtained from the subject for the presence of (73) Assignee: THE INSTITUTE FOR ETHNO elevated levels of neurotoxic amino acids or neurotoxic MEDICINE, Provo, UT derivatives thereof associated with neurological disorders. In particular, methods are disclosed for diagnosing a neu (21) Appl. No.: 11/760,668 rological disorder in a subject, or predicting the likelihood of developing a neurological disorder in a Subject, by deter (22) Filed: Jun. 8, 2007 mining the levels of B-N-methylamino-L-alanine (BMAA) Related U.S. Application Data in a tissue sample obtained from the subject. Methods for screening for environmental factors associated with neuro (63) Continuation of application No. 10/731,411, filed on logical disorders are disclosed. Methods for inhibiting, treat Dec. 8, 2003, now Pat. No. 7,256,002.
  • Taurine and Osmoregulation: Taurine Is a Cerebral Osmoprotective Molecule in Chronic Hypernatremic Dehydration1

    Taurine and Osmoregulation: Taurine Is a Cerebral Osmoprotective Molecule in Chronic Hypernatremic Dehydration1

    003 1-3998/88/2301-0035$02.00/0 PEDIATRIC RESEARCH Vol. 23, No. 1, 1988 Copyright 0 1988 International Pediatric Research Foundation, Inc. Printed in US.A. Taurine and Osmoregulation: Taurine Is a Cerebral Osmoprotective Molecule in Chronic Hypernatremic Dehydration1 HOWARD TRACHTMAN, RANDY BARBOUR, JOHN A. STURMAN, AND LAURENCE FINBERG Departments of Pediatrics and Clinical Chemistry, State University of New York, Health Science Center at Brooklyn; and the Department of Developmental Biochemistry, Institute for Basic Research in Developmental Disabilities, Staten Island, New York ABSTRACT. We studied the effect of 8-wk dietary taurine ative during more prolonged hypernatremia, namely the intra- depletion on the vulnerability to hypernatremic dehydra- cellular accumulation of osmoprotective molecules. These sol- tion in postweanling kittens. While experimental taurine utes, previously referred to as "idiogenic" (3), consist in part of depletion was not associated with increased susceptibility amino acids, taurine in particular (4). If rapid rehydration is to acute hypernatremia (1.5 M NaCl/NaHC03 35 ml/kg attempted, these molecules cannot exit from the cells quickly body weight, single injection), there was an increase in enough and cellular swelling may ensue due to the sudden mortality (five of seven versus one of seven, p = 0.05) and reversal of the osmolal gradient. seizure activity (three of seven versus none of seven, p = The present studies were designed in kittens to assess the role 0.08) in taurine-depleted compared to taurine-replete kit- of taurine as a cerebral osmoprotective molecule in CHD. These tens rendered chronically hypernatremic over 96 h. Fur- animals synthesize little taurine owing to low levels of CSAD thermore, there was a significant decrease in brain cell activity (5, 6).
  • Taurine Conjugated Bile Acids in Healthy Subjects

    Taurine Conjugated Bile Acids in Healthy Subjects

    Gut: first published as 10.1136/gut.24.3.249 on 1 March 1983. Downloaded from Cl1t,I98-3. 24, 2249-252 Postprandial plasma concentrations of glycine and taurine conjugated bile acids in healthy subjects K LINNET Fronti tlh,e Departmen t of (-Ctlnicll (Chew istrrv ktred(riksbe,rg, Hospital. C(openIhagen Dentllark SUMMARY Fasting and postprandial plasma concentrations of glycine and taurine conjugates of cholic, chenodeoxycholic. and deoxvcholic acid were measured by a high pressure liquid chromatography-enzymatic assay in nine healthy subjects. The mean value of each bile acid concentration increased significantly (2 4-4.7 times) in the postprandial period. The total glycine/taurine ratio of 2.5 in the fasting state increased significantly to a maximum value of 3 3 at one to 18 hours postprandially and then declined. This shift in glycine/taurine ratio shows, that the relative increase in concentrations of glvcine conjugates exceeds the relative increase in concentrations of taurine conjugates in the early postprandial period, and supports the view that there is significant absorption of glycine conjugated bile acids from the proximal small intestine. Measurements of fasting and postprandial serum Methods concentrations of individual bile acids have so far been performed by radioimmunoassav or gas SUBJECTS chromatographv.' Before analvsis by aas The study was carried out in nine healthy http://gut.bmj.com/ chromatography the bile acids are deconjugated. so volunteers, four women and five men, with a mean that both free and conjugated bile acids are age of 24 years (interval 17-40 years). The subjects measured and no information is obtained regarding were fasted overnight, and in the morning blood the amino acid of the conjugate (glycine or taurine).
  • Systemic Gut Microbial Modulation of Bile Acid Metabolism in Host Tissue Compartments

    Systemic Gut Microbial Modulation of Bile Acid Metabolism in Host Tissue Compartments

    Systemic gut microbial modulation of bile acid metabolism in host tissue compartments Jonathan R. Swanna,b, Elizabeth J. Wanta, Florian M. Geiera, Konstantina Spagoua, Ian D. Wilsonc, James E. Sidawayd, Jeremy K. Nicholsona,1, and Elaine Holmesa,1 aBiomolecular Medicine, Department of Surgery and Cancer, Faculty of Medicine, Imperial College, London SW7 2AZ, United Kingdom; bDepartment of Food and Nutritional Sciences, School of Chemistry, Food and Pharmacy, The University of Reading, Reading RG6 6AP, United Kingdom; cAstraZeneca, Department of Clinical Pharmacology, Drug Metabolism and Pharmacokinetics; and dAstraZeneca, Global Safety Assessment, Cheshire SK10 4TG, United Kingdom Edited by Todd R. Klaenhammer, North Carolina State University, Raleigh, NC, and approved July 30, 2010 (received for review May 26, 2010) We elucidate the detailed effects of gut microbial depletion on the deconjugation, dehydrogenation, dehydroxylation, and sulfation bile acid sub-metabolome of multiple body compartments (liver, reactions (8) to produce secondary bile acids, which are reabsorbed kidney, heart, and blood plasma) in rats. We use a targeted ultra- and returned to the liver for further processing. performance liquid chromatography with time of flight mass-spec- Historically, bile acids have been primarily viewed as detergent trometry assay to characterize the differential primary and secondary molecules important for the absorption of dietary fats and lipid- bile acid profiles in each tissue and show a major increase in the soluble vitamins in the small intestine and the maintenance of proportion of taurine-conjugated bile acids in germ-free (GF) and cholesterol homeostasis in the liver. However, their role in the antibiotic (streptomycin/penicillin)-treated rats. Although conjugated mammalian system is much broader than this, and they are now bile acids dominate the hepatic profile (97.0 ± 1.5%) of conventional recognized as important signaling molecules with systemic endo- animals, unconjugated bile acids comprise the largest proportion of crine functions.
  • Taurine-Deficient Dilated Cardiomyopathy in Dogs October 16Th, 2018

    Taurine-Deficient Dilated Cardiomyopathy in Dogs October 16Th, 2018

    TAURINE-DEFICIENT DCM IN DOGS Taurine-Deficient Dilated Cardiomyopathy in Dogs October 16th, 2018 What is this disease? Dilated Cardiomyopathy (DCM) is a form of heart disease in which the heart muscle becomes weak and the heart becomes enlarged. This results in poor heart function, leading to exercise intolerance, collapse, pale gums, coughing, and panting. Eventually, DCM results in complete heart failure. Many dogs show no symptoms until the disease is quite advanced. DCM may be caused by a genetic predisposition in many breeds of dogs. However, the current concern is that cardiologists have been diagnosing DCM in breeds of dogs not generally genetically predisposed—especially golden retrievers. In July, the FDA issued a warning that certainly types of diets may be contributing to the development of nutritional deficiencies in dogs. The cases reported to the FDA have been patients who have developed taurine-deficient DCM. Taurine is an amino acid that dogs are normally able to synthesize from other amino acids in the their food. Many dog foods also add taurine specifically. Cardiologists noticed a trend that pets who were developing taurine-deficient DCM were mainly eating one of three categories of food: boutique, exotic-ingredient, or grain-free diets. The common link is that these diets contain one or more suspect ingredients: Legumes Potatoes Peas Red potatoes ▹ ▹ To Stay Updated... ▹ Chickpeas ▹ White potatoes ▹ Lentils ▹ Sweet potatoes LHV’s Facebook Page ▹ Soybeans ▹ Beans Facebook group “Taurine- The majority of these companies also do not employ a PhD nutritionist or a Deficient Dilated Cardiomyopathy” veterinary nutritionist, and often these foods have not been subjected to feeding trials on dogs.
  • Amino Acids Amino Acids

    Amino Acids Amino Acids

    Amino Acids Amino Acids What Are Amino Acids? Essential Amino Acids Non Essential Amino Acids Amino acids are the building blocks of proteins; proteins are made of amino acids. Isoleucine Arginine (conditional) When you ingest a protein your body breaks it down into the individual aminos, Leucine Glutamine (conditional) reorders them, re-folds them, and turns them into whatever is needed by the body at Lysine Tyrosine (conditional) that time. From only 20 amino acids, the body is able to make thousands of unique proteins with different functions. Methionine Cysteine (conditional) Phenylalanine Glycine (conditional) Threonine Proline (conditional) Did You Know? Tryptophan Serine (conditional) Valine Ornithine (conditional) There are 20 different types of amino acids that can be combined to make a protein. Each protein consists of 50 to 2,000 amino acids that are connected together in a specific Histidine* Alanine sequence. The sequence of the amino acids determines each protein’s unique structure Asparagine and its specific function in the body. Asparate Popular Amino Acid Supplements How Do They Benefit Our Health? Acetyl L- Carnitine: As part of its role in supporting L-Lysine: L-Lysine, an essential amino acid, is mental function, Acetyl L-Carnitine may help needed to support proper growth and bone Proteins (amino acids) are needed by your body to maintain muscles, bones, blood, as support memory, attention span and mental development. It can also support immune function. well as create enzymes, neurotransmitters and antibodies, as well as transport and performance. store molecules. N-Acetyl Cysteine: N-Acetyl Cysteine (NAC) is a L-Arginine: L-Arginine is a nonessential amino acid form of the amino acid cysteine.